Company / R&D Expense
Harvard Apparatus Regenerative Technology, Inc. R&D Expense History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$2.7M
FY2025
5-year range
$1.6M / $3.1M
FY2021-FY2025
Trend
+14.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $2M in FY2021 to $8M in FY2016.
Based on SEC 10-K filings.
$3M in FY2025 with a 10-year CAGR of -5.7%.
Declined from $3M to $3M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +5.1%
- 10-Year CAGR
- -5.7%
Key checks
Key Insights
- 5-year CAGR of +5.1%, indicating consistent growth.
- In FY2025, r&d expense increased 14.8% year-over-year.
- Peak r&d expense was recorded in FY2016.
- Lowest r&d expense in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -41.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7M | +14.8% |
| FY2024 | $2.3M | -24.6% |
| FY2023 | $3.1M | +92.3% |
| FY2021 | $1.6M | -23.1% |
| FY2020 | $2.1M | -57.4% |
| FY2019 | $4.9M | +23.9% |
| FY2018 | $3.9M | -48.4% |
| FY2017 | $7.6M | -0.2% |
| FY2016 | $7.6M | +58.9% |
| FY2015 | $4.8M | -6.5% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026